Interventional News 97 Highlights:
- First RETNET data show no difference in progression-free survival between TAE and TACE for neuroendocrine liver tumours
- Key research updates in lower extremity peripheral arterial disease (PAD) from the Leipzig Interventional Course (LINC 2025; 28–30 January, Leipzig, Germany) and the International Symposium of Endovascular Therapy (ISET; 2–5 February, Hollywood, USA)
- Interview: Ziv Haskal (Charlottesville, USA) gives pragmatic shape to the emerging future of resorbable microspheres in MSK embolization
- Profile: Sarah White (Milwaukee, USA)
- Research supports combined treatment approach for erectile dysfunction due to mixed arteriovenous disease
